Pentobarbital is a medicine used to help people fall asleep or stay asleep. It's sometimes used for sedation, but it's more commonly used to help people go to sleep quickly. It's usually taken by mouth. It's important to know that it might not work as well after a few weeks of taking it regularly.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Pentobarbital is a barbiturate, an older type of sedative that slows activity in the brain and nervous system. In the United States it is given only as an injection, by doctors and nurses, mostly in hospitals. The injection has been sold under the brand name Nembutal Sodium and is also available under its generic name. The Nembutal capsules, liquid and suppositories once used at home have been discontinued in the US. Its approved uses are calming a person (sedation), relaxing them before anesthesia, short-term treatment of sleeplessness and, at much higher doses, emergency control of seizures that will not stop, including status epilepticus (a seizure that lasts too long or keeps recurring without recovery in between). In practice its role today is narrower. In intensive care units it is used to put a person into a medically induced coma when seizures continue despite other medicines, or when pressure inside the skull stays dangerously high after a severe brain injury. Some children's hospitals also use it, sometimes prepared as a liquid by mouth or as a suppository, to keep young children still for MRI or CT scans. Pentobarbital is now rarely used for insomnia. It loses most of its effect on sleep within about two weeks of nightly use, and its risks of dependence and overdose make it a poor choice for ongoing sleep problems.
GABA (gamma-aminobutyric acid) is the brain's main calming chemical messenger. When it attaches to nerve cells, it opens channels that make those cells less likely to fire. Pentobarbital strengthens this effect, so nerve activity across the brain slows down. The result depends heavily on dose. A small dose causes calm and drowsiness, a larger one produces sleep, and very high doses produce anesthesia and deep coma. The same slowing explains both its uses and its dangers. At high doses it can quiet the abnormal electrical activity of a prolonged seizure and lower the brain's energy and oxygen needs, which can reduce pressure inside the skull, although exactly how that pressure falls is not fully understood. It also slows breathing and lowers blood pressure. Given into a vein, pentobarbital starts working almost immediately. The liver breaks it down. After long infusions it builds up in body fat, so sedation can last much longer than a single dose would suggest.
Pentobarbital is given only by a clinician, either into a vein (IV) or as a deep injection into a large muscle. The dose is set individually from age, weight, the reason for treatment and how the person responds. It is lower for older or frail people and for those with liver or kidney disease. IV doses are given slowly, in small steps, while breathing, heart rate and blood pressure are watched and equipment to support breathing is ready. Injecting it too quickly is a recognized cause of stopped breathing and a sudden drop in blood pressure. For a medically induced coma, pentobarbital runs as a continuous IV infusion in intensive care. The person is on a breathing machine, and the team often uses EEG (electroencephalography, a recording of the brain's electrical activity) to adjust the infusion until seizure activity is suppressed. For a child's scan, the sedation team gives a single planned dose and monitors the child afterward. Because no oral or rectal pentobarbital is sold in the US, hospitals that use those routes prepare them in their own pharmacy.
Drowsiness is the most common effect. Less often, people feel dizzy, confused, unsteady or nauseated, or have a headache or nightmares. Some people, especially older or frail adults, react the opposite way and become agitated, excited or confused rather than calm. The most serious effects are slowed or stopped breathing and low blood pressure. They are the reason pentobarbital is given only where breathing and circulation can be monitored and supported. The injection is also strongly alkaline, and if it leaks out of the vein or enters an artery it can damage the surrounding tissue, so pain or burning in the arm during an injection should be reported to the nurse right away. During a long medically induced coma, other problems can include low blood pressure that needs medicines to support it, poor tolerance of tube feeding, infections including bloodstream infections, and toxicity from propylene glycol, an ingredient in the injection. Rare allergic reactions include rashes, peeling skin and swelling of the face or throat.
Pentobarbital adds to the effects of anything else that slows the brain and breathing, including alcohol, opioid pain medicines, anti-anxiety medicines, other sleep aids and sedating antihistamines. Together these can deepen sedation and slow breathing more than either would alone, and alcohol greatly lowers the amount of a barbiturate that can be fatal. Alcohol should be avoided after receiving it. Barbiturates also speed up the liver enzymes that break down many other drugs, which can make those drugs less effective. This matters most for warfarin (a blood thinner whose dose may need adjusting), corticosteroids such as prednisone, and hormonal birth control, which may fail, so a backup method is worth discussing. Doses of these medicines may need rechecking both when the barbiturate starts and when it stops. Valproate, a seizure medicine, works the other way and can raise barbiturate levels. Pentobarbital should not be used by people with porphyria (a group of rare inherited disorders in how the body makes heme, part of hemoglobin) or a past allergic reaction to a barbiturate. It is used cautiously, if at all, in people with depression, suicidal thoughts or a history of substance misuse, and at lower doses in liver disease. It is a Schedule II controlled substance and can be habit forming. After prolonged regular use, stopping suddenly can cause severe withdrawal, including seizures and delirium that can be fatal, so the dose is reduced gradually. Barbiturates can harm a developing baby, and babies exposed late in pregnancy can go through withdrawal after birth. Small amounts pass into breast milk.
What happens depends on why pentobarbital is used. For a scan or procedure, sleepiness comes on quickly, especially with an IV dose. Drowsiness and unsteadiness can continue after the procedure, so a child needs close supervision at home, and an adult who received it should not drive or operate machinery until fully alert. In intensive care, a medically induced coma is a serious step taken when other treatments have failed. The person is kept deeply unconscious on a ventilator while the team watches brain activity, blood pressure and signs of infection, and the infusion is reduced gradually when it is time to stop. Because pentobarbital accumulates in body fat, waking up can take much longer than after most sedatives. Outcomes depend largely on the illness that made the coma necessary. For severe traumatic brain injury, barbiturate coma can lower pressure inside the skull, but studies have not shown that it improves survival or recovery, and about one in four people treated develop low blood pressure. That is why it is reserved for pressure that does not respond to other measures. Pentobarbital is not a long-term sleep medicine. If it is used for sleeplessness at all, it is limited to short courses because it stops working within about two weeks.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Pentobarbital, what you've noticed, or ask the community a question.